NTNurgul Toktogulova

Nurgul Toktogulova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nurgul Toktogulova has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Features of the Pathogenesis and Course of Metabolic-Associated Fatty Liver Disease Under Hypobaric Hypoxia

    by N. Toktogulova

    Metabolically associated fatty liver disease (MAFLD) is one of the most common chronic liver diseases, characterized by lipid accumulation and inflammation leading to steatohepatitis and fibrosis. The influence of hypobaric hypoxia, typical for high-altitude regions, on the pathogenesis of MAFLD remains poorly understood, despite its potential role in metabolic and inflammatory regulation. To investigate the features of the pathogenesis and course of MAFLD under hypobaric hypoxia using an experimental animal model. The study was conducted on 191 male rats weighing 150–250 g. MAFLD was induced by a fructose-fat diet (FFD) for 5 and 10 weeks. Experimental groups included lowland (Bishkek, 800 m) and hypobaric hypoxia (barochamber, 6000 m, 6 h/day). Biochemical parameters (ALT, AST, bilirubin, total protein, lipid profile, cytokines) and hepatic morphology were analyzed. Therapeutic interventions included normal diet, vitamin E, and metformin. FFD induced marked metabolic and morphological changes consistent with steatohepatitis. Under hypobaric hypoxia, rats exhibited significantly lower ALT and AST (p<0.001) and moderate hyperbilirubinemia, indicating hepatic hypoergy and adaptive cholestasis. Cytokine index (TNF-α/IL-4) suggested attenuated inflammation. Morphologically, hepatocyte and nuclear hypertrophy, ductular proliferation, and regenerative signs were observed. The combination of dietary normalization and vitamin E therapy produced the most significant improvement in biochemical and histological parameters. Hypobaric hypoxia modulates the course of MAFLD by reducing cytolytic and inflammatory activity while enhancing hepatic regeneration. These findings suggest that hypobaric hypoxia may serve as both a valuable experimental model and a potential adjunctive factor in the rehabilitation of patients with metabolic liver disease.

  • Proteomic Signatures and Blood Adenosine Triphosphate Levels as Markers of Empagliflozin Efficacy in Type 2 Diabetes Mellitus and Heart Failure

    by Uulkan Omurzakova, Matthias Breidert, Markus Donner, Nurgul Toktogulova, Maria Moldobaeva, Angélique Quartier, Pierre Eftekhari

    Empagliflozin, a sodium-glucose cotransporter 2 inhibitor, is approved for the treatment of type 2 diabetes mellitus and heart failure. Its known ability to enhance mitochondrial adenosine triphosphate production and improve cardiac function led us to investigate whether blood adenosine triphosphate levels could serve as a predictive biomarker for treatment response. This prospective study included 120 patients from Kyrgyzstan: 49 with type 2 diabetes mellitus, 43 with heart failure, and 28 with both type 2 diabetes mellitus and heart failure. The mean age of the study population was 63.9±7.1 years, with no significant age difference between groups. Patients received oral empagliflozin at a dose of either 10 or 25 mg daily for 12 weeks. Adenosine triphosphate activity was measured in erythrocytes from whole blood samples before and after treatment. In vitro assays were also performed, incubating patient blood samples with empagliflozin at concentrations of 0.1, 1, and 10 µM. In patients with type 2 diabetes mellitus, empagliflozin significantly reduced body mass index (p=0.001), though HbA1c levels remained unchanged. Among heart failure patients, treatment resulted in a significant increase in left ventricular ejection fraction (p=0.028) and a decrease in B-type natriuretic peptide levels (p=0.01). Blood adenosine triphosphate concentrations increased significantly following empagliflozin treatment in both type 2 diabetes mellitus and heart failure groups. Proteomic analysis identified 12 differentially expressed proteins—ADIPOQ, ARG1, CST3, CPPED1, GSTO1, FN1, ITIH4, LCN2, LCP1, MIF, PCMT1, and SERPINA3—that are functionally linked to type 2 diabetes mellitus and/or heart failure pathophysiology. Our data suggest that blood adenosine triphosphate activity may serve as a potential biomarker for clinical response to empagliflozin in patients with type 2 diabetes mellitus and heart failure. Further studies are warranted to validate these exploratory findings and to evaluate the sensitivity, specificity, and predictive value of blood adenosine triphosphate as a biomarker in these populations.


  • Open Access

    Understanding Primary School Teachers’ Mathematical Knowledge for Teaching

    by Yasmin A. Sitabkhan, Aida Alikova, Nurgul Toktogulova, Adema Zholdoshbekova, Wendi Delcene Ralaingita, Jonathan Michael Bradley Stern

    We present the results from an exploratory study that aimed to measure teachers’ specialized knowledge in early mathematics during a pilot of an educational intervention using the Foundational Mathematical Knowledge for Teaching (FMKT) survey. The survey was administered to 323 teachers in the Kyrgyz Republic in 2021. We delve into survey results at two timepoints (pre- and post-intervention) to showcase the areas in which the intervention was successful and identify ongoing challenges in teacher knowledge. We found that the FMKT provided detailed, specific information on teacher learning and is an example of one way to center teacher knowledge in an instructional intervention.


  • The Influence of Growth Hormone and Insulin-like Growth Factor 1 on Anthropometric Parameters in Children with Type 1 Diabetes Mellitus

    by F. Uvaidillaeva, R. Tuhvatshin, N. Junushalieva, N. Toktogulova, T. Kaliev

    The goal is to study the indicators of somatotropic hormone and insulin-like growth factor-1 to assess the effect on anthropometric indicators of children with type 1 diabetes mellitus. 74 children with type 1 diabetes mellitus and 14 children in the control group were examined. Average age 12±3.5 years. The assessment of physical development was carried out on the basis of an assessment of anthropometric indicators — height and body weight with the calculation of BMI and compared with centile tables. Determination of the concentration of hormones such as GH and IGF-1 was determined by special ELISA kits using the enzyme immunoassay method using an analyzer (Mindray MR-96A). The obtained data were subjected to statistical processing. It was revealed that 8 (36.4%) boys and the majority of girls 14 (63.6%) achieved the target level of glycated hemoglobin. Children with T1DM are statistically significant and stunted in height and weight compared to healthy children in the control group.

  • Energy Metabolism in Residents in the Low- and Moderate Altitude Regions of Central Asia with MAFLD and Type 2 Diabetes Mellitus

    by Nurgul Toktogulova, Matthias Breidert, Judith Eschbach, Indira Kudaibergenova, Uulkan Omurzakova, Feruzakhan Uvaidillaeva, Bermet Tagaeva, Roza Sultanalieva, Pierre Eftekhari

    The knowledge about the features of energy metabolism in MAFLD in the population living at different climatic and geographic heights is lacking. The goal of this study is to explore the biochemical parameters of blood and erythrocyte energy consumption in patients with MAFLD with and without DM2 living in the low- and moderate-altitude regions of Central Asia. Our study was carried out on patients living in low-altitude mountains: Bishkek, altitude=750–800 m; n=67 (MAFLD with DM 2: n=24; MAFLD without DM2: n=25; control: n=18), and At-Bashy District, Naryn Region, altitude=2046–2300 m; n=58 (MAFLD with DM2: n=28; MAFLD without DM2: n=18; control: n=12). Non-alcoholic fatty liver disease was diagnosed according to history, laboratory tests, liver ultrasound, and exclusion of other liver diseases. The level of liver fibrosis was determined using the FIB-4 score. Blood adenosine 5′-triphosphate (ATP) was determined using the CellTiter-Glo method. Healthy residents living in moderate altitudes have significantly higher levels of cytosolic ATP in their blood (p+≤+0.05) than residents living in low mountains. MAFLD is characterized by an increase in the level of ATP concentration in their blood. ATP concentration decreased significantly in patients with MAFLD with DM2 living in moderate-altitude in comparison to those living in low-altitude mountains. The results suggest that chronic altitude hypoxia leads to a breakdown in adaptive mechanisms of energy metabolism of ATP in patients with MAFLD with type 2 DM.


  • Systematic Review of Clinical Guidelines for the Treatment of Functional Dyspepsia

    by L. Atabaeva, N. Toktogulova, A. Smirnova, T. Kalybekov, M. Dzhumabaev

    An analysis of the literature data on the treatment of functional dyspepsia (FD) was performed. In the Kyrgyz Republic there have been no studies on the prevalence of FD, there are no protocols for diagnosis and management of patients with this pathology. We analyzed clinical recommendations on FD of the leading five world gastroenterological associations, the comparison of which showed the general principles of patient management, as well as some discrepancies.

  • A Systematic Review of Clinical Guidelines for the Treatment of Gastroesophageal Reflux Disease

    by A. Smirnova, N. Toktogulova, L. Atabaeva, T. Kalybekov, M. Dzhumabaev

    Gastroesophageal reflux disease (GERD) is a common condition among adults and children. The estimated prevalence ranges from 8 to 33%, and the numbers are only expected to increase over time. Heartburn and regurgitation are considered classic symptoms of the disease, but it can also present with a variety of atypical, extra-esophageal manifestations, which reduces patients’ quality of life and leads to Under-Diagnosis. Treatment in adults involves a combination of lifestyle modification with pharmacologic, endoscopic, or surgical interventions. Scientific societies from Europe, America, Asia-Pacific, South America, and Central Asia have proposed guidelines based on current understanding of gastroesophageal reflux disease. The review article presents an analysis of treatment regimens from ten different world guidelines for the diagnosis and treatment of GERD, which revealed in most cases similar algorithms of patient management. Some differences in medication approaches are revealed, which is probably due to the different level of health care in each country. Differences in lifestyle modification were considered in the sphere of identified new scenarios of GERD pathogenesis.

  • State of Pro- and Anti-inflammatory Cytokines Residents of Kyrgyzstan With Impaired Fat Metabolism Before and During the Covid-19 Pandemic

    by N. Toktogulova, R. Gasanov

    Studies on the role of lipid metabolism disorders in the progression of such life-threatening conditions as heart attacks, acute cerebrovascular accident and diabetes mellitus have been updated during the period of a new coronavirus infection. COVID-19 is an infectious disease characterized by impaired immune system processes, the production of a large number of pro-inflammatory cytokines with multiple organ damage. The article is devoted to the study of the problem of lipid spectrum disorders in patients after COVID-19 from the standpoint of the progression of chronic inflammation and changes in the cytokine status. We selected and studied the results of analyzes of 473,627 respondents in the period from 2010 to 2022. Two conditional groups were considered: before the COVID-19 pandemic and during the pandemic. A comparative analysis of the levels of total cholesterol, triglycerides, HDL, LDL was carried out. The article reveals the actual problem of the impact of coronavirus infection on the risks of the cardiovascular system.

  • Open Access

    ОСВЕДОМЛЕННОСТЬ ВРАЧЕЙ О ЖИРОВОМ ГЕПАТОЗЕ

    by Алтынай Садыкова, Нургуль Токтогулова, Сапарбу Тобокалова, Мээржан Кадырбердиева, Сабира Маматова

    Статья содержит сообщение об осведомленности врачей о жировом гепатозе среди населения. Объектами исследования было анкетирование врачей для оценки осведомленности врачей о НАЖБП с 15 ноября по 25 ноября 2022 г. Установлено, что у многих пациентов с метаболическим синдромом имеется жировая дистрофия гепатоцитов, а у половины обнаруживается стеатогепатит. Для достоверной оценки теоретической базы об НАЖБП участие врачей было добровольным и анонимным. Были опрошены 40 врачей из города Бишкек и 40 врачей из города Ош. Респонденты самостоятельно заполняли анкеты без участия интервьюера, каждому респонденту были заданы по 15 вопросов, касающихся их знаний о жировом гепатозе. После опроса проведен анализ анкетирования.